Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Endexx Corp EDXC

Endexx Corporation develops hemp-derived, cannabidiol (CBD)-based products, each formulated to address key segments of the health and wellness market. Through its subsidiaries, the Company sells oils, extracts, topicals, and pet products, all with the shared purpose of supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site www.cbdunlimited.com... see more

PINL:EDXC - Post Discussion

Endexx Corp > $EDXC - Strategic Marketing Partnership with XVI Ventures
View:
Post by StockHighAlert on Oct 23, 2023 12:20pm

$EDXC - Strategic Marketing Partnership with XVI Ventures

Strategic Marketing Partnership with XVI Ventures for Consumer Product in Italy; Endexx Corporation (Stock Symbol: EDXC) $EDXC

Endexx Corporation (OTCMKTS:EDXC)

CAVE CREEK, ARIZONA, UNITED STATES , October 20, 2023 /EINPresswire.com/ -- Strategic Marketing Partnership with XVI Ventures for Consumer Product in Italy; Year-Over-Year Quarterly Revenues Grew 1013% from $254,686 to $2,833,378: Endexx Corporation (Stock Symbol: EDXC)


Developing and Marketing All Natural, Plant-Derived Consumer Products.

Also Involved with Strategic Partners in the Entertainment, Marketing, and Distribution Arenas.

New Strategic Partnership with Italy-Based Marketing Firm XVI Ventures.

HYLA Currently Sold in 3,500 Stores in Italy at 7.5% Growth Rate per Quarter

$400,000 Reorder for Product HYLA; Highlights Accelerating Product Demand.


Quarter Ending March 31, 2023 Showed Increasing Revenues Year-Over-Year of 1013% and Six Month Revenues Grew 528%.


Veteran Abbot Laboratories Sales Manager for Middle East and Africa Brings Industry Experience to EDXC.

Endexx Corporation (OTCQB: EDXC) owns Hyla currently markets its proprietary guarana and L-Dopa-based consumer products in a wide variety of flavors. The EDXC Hyla device is the first product to be produced in this manner in the United States. Hyla is currently being distributed in multiple countries around the world.

Each EDXC Hyla blend is a combination of Guarana, a functional plant extract from Brazil, and botanical aromas for a unique flavor. All EDXC custom botanical products are created in a state-of-the-art lab and include an innovative anti-counterfeit solution to keep you safe from clones.

READ FULL ARTICLE HERE >>> 
https://www.einpresswire.com/article/663113435/xvi-venture-partnerships-for-consumer-product-in-italy-revenues-grew-1013-to-2-833-378-endexx-stock-symbol-edxc

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities